Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) rose sharply in today's pre-market trading after the company reported topline results from Phase 2 CANYON trial of Sevasemten in individuals with becker muscular dystrophy.
Edgewise Therapeutics shares jumped 26.5% to $35.00 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
- Wall Street’s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
